These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19727125)

  • 21. The role of oxidative stress in chronic kidney disease.
    Massy ZA; Stenvinkel P; Drueke TB
    Semin Dial; 2009; 22(4):405-8. PubMed ID: 19708991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial function, CRP and oxidative stress in chronic kidney disease.
    Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
    J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidney.
    Chatterjee PK; Patel NS; Kvale EO; Brown PA; Stewart KN; Mota-Filipe H; Sharpe MA; Di Paola R; Cuzzocrea S; Thiemermann C
    Am J Nephrol; 2004; 24(2):165-77. PubMed ID: 14752229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease.
    Wratten ML; Galaris D; Tetta C; Sevanian A
    Antioxid Redox Signal; 2002 Dec; 4(6):935-44. PubMed ID: 12573142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.
    Oberg BP; McMenamin E; Lucas FL; McMonagle E; Morrow J; Ikizler TA; Himmelfarb J
    Kidney Int; 2004 Mar; 65(3):1009-16. PubMed ID: 14871421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of oxidative stress on chronic kidney disease progression.
    Putri AY; Thaha M
    Acta Med Indones; 2014 Jul; 46(3):244-52. PubMed ID: 25348188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of endothelial dysfunction in chronic kidney disease.
    Malyszko J
    Clin Chim Acta; 2010 Oct; 411(19-20):1412-20. PubMed ID: 20598675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease.
    Himmelfarb J
    Cardiol Clin; 2005 Aug; 23(3):319-30. PubMed ID: 16084281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress.
    Fujii H; Nishijima F; Goto S; Sugano M; Yamato H; Kitazawa R; Kitazawa S; Fukagawa M
    Nephrol Dial Transplant; 2009 Jul; 24(7):2089-95. PubMed ID: 19188341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oxidative stress and endothelial dysfunction].
    Urso C; Caimi G
    Minerva Med; 2011 Feb; 102(1):59-77. PubMed ID: 21317849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
    Stenvinkel P
    J Ren Nutr; 2003 Apr; 13(2):144-8. PubMed ID: 12671839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?].
    Font R; Prats M; Gutiérrez C; Bardají A; Lalana M; Marsillach J; Camps J; Martínez Vea A
    Nefrologia; 2009; 29(3):228-35. PubMed ID: 19554056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?
    Himmelfarb J
    Semin Dial; 2004; 17(6):449-54. PubMed ID: 15660575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress in chronic renal failure as a cardiovascular risk factor.
    Siems W; Quast S; Carluccio F; Wiswedel I; Hirsch D; Augustin W; Hampi H; Riehle M; Sommerburg O
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S12-9. PubMed ID: 12227720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-density lipoprotein-cholesterol-induced endothelial dysfunction and oxidative stress: the role of statins.
    Hermida N; Balligand JL
    Antioxid Redox Signal; 2014 Mar; 20(8):1216-37. PubMed ID: 23924077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
    Cases A; Vera M; López Gómez JM
    Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress - chronic kidney disease - cardiovascular disease: A vicious circle.
    Ravarotto V; Simioni F; Pagnin E; Davis PA; Calò LA
    Life Sci; 2018 Oct; 210():125-131. PubMed ID: 30172705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].
    Bertinchant JP
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation.
    Rodríguez-Mañas L; El-Assar M; Vallejo S; López-Dóriga P; Solís J; Petidier R; Montes M; Nevado J; Castro M; Gómez-Guerrero C; Peiró C; Sánchez-Ferrer CF
    Aging Cell; 2009 Jun; 8(3):226-38. PubMed ID: 19245678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endothelin system and its antagonism in chronic kidney disease.
    Dhaun N; Goddard J; Webb DJ
    J Am Soc Nephrol; 2006 Apr; 17(4):943-55. PubMed ID: 16540557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.